https://www.selleckchem.com/products/nx-1607.html
1, 95% CI 1.04-1.24, p=0.003). Patients with MTC had significantly lower one-year survival. Our study suggests that the implementation of ROTEM and the use of cryoprecipitate play significant roles in the development of MTC in LT. The benefits and risks of cryoprecipitate transfusion should be carefully evaluated before administration. Our study suggests that the implementation of ROTEM and the use of cryoprecipitate play significant roles in the development of MTC in LT. The benefits and risks of cryoprecipitate transfusion should be c
Like
Comment
Share
